CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

SeaCrest Wealth Management LLC trimmed its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 38.2% in the fourth quarter ...

AdvisorNet Financial Inc lessened its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 14.1% during the fourth ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on January 10 and set a price target of ...

Analysts might have found just the stocks to buy, too. Here are three high-yield dividend stocks Wall Street thinks will soar ...

Valuation metrics highlight Ford’s appeal to bargain hunters, with a P/E of 11.07 and a forward P/E of just 5.74. For income seekers, Ford’s 6.18% dividend yield is particularly enticing. Technically, ...

There are big, complex, significant, impactful prosecutions out there,” U.S. Attorney Zachary Cunha said. He plans to stay on ...

With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...

Can Walgreens Boots Alliance stock continue rising, or should investors use the stock's recent gain as an opportunity to exit ...

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...